ProShares Ultra NASDAQ Biotechnology
22 hedge funds and large institutions have $19.2M invested in ProShares Ultra NASDAQ Biotechnology in 2014 Q2 according to their latest regulatory filings, with 7 funds opening new positions, 7 increasing their positions, 5 reducing their positions, and 5 closing their positions.
Holders
22
Holders Change
+2
Holders Change %
+10%
% of All Funds
0.63%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
7
Increased
7
Reduced
5
Closed
5
Calls
$8.88M
Puts
$17.3M
Net Calls
-$8.38M
Net Calls Change
-$6.97M